Reducing complications in type 2 diabetes.
Poirier
S J
SJ
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D048909:Diabetes Complications; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003928:Diabetic Nephropathies / Q000517:prevention & control*; D003929:Diabetic Neuropathies / Q000517:prevention & control*; D003930:Diabetic Retinopathy / Q000517:prevention & control*; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy / Q000209:etiology; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D011507:Proteinuria / Q000188:drug therapy* / Q000209:etiology; D016032:Randomized Controlled Trials as Topic
D000806:Angiotensin-Converting Enzyme Inhibitors